STRENGTHENING EVIDENCE THROUGH HEALTH RESEARCH WHERE MOST PEOPLE ACCESS HEALTHCARE, RACGP joins consortium and calls for practice-based research network in primary health
With
Dr Michael Wright GP, President
The Royal Australian College of General Practitioners (RACGP) &
Associate Professor,
International Centre for Future Health Systems (ICFHS)
Australian Health Journal segment
Filmed in Sydney | March 2025
In February 2025, the Australian Government committed over $22 million for primary care research, including $5.2m awarded to Professor Michael Kidd, Director of the International Centre for Future Health Systems at UNSW and recently appointed Australia’s Chief Medical Officer, to lead the establishment of one of the largest research collaborations in Australia focused on improving primary care.
The Royal Australian College of GPs says a new national multidisciplinary consortium for primary care research is a positive step forward to improve patient care.
The RACGP is a member of the National Multidisciplinary Primary Care Research, Policy and Advocacy Consortium, which involves 100 primary care researchers from 20 universities from across the country.
RACGP President Dr Michael Wright said: “Every year more than 22 million Australians see a specialist GP for their essential health care, making general practice is the most accessed part of our health system.
“Yet research in general practice is vastly underrepresented and underfunded. General practice receives less than 2% of our national medical research funding.
“This new consortium is an important and exciting opportunity to design, test and innovate models of care to better meet the needs of patients across Australia, and I’m proud the RACGP is a member.
“The RACGP is calling for all political parties to commit to funding a national practice-based research network, like they have in Canada and the United Kingdom.
“These networks have proven to be immensely valuable overseas.
“We’re also calling for funding to test how multidisciplinary practice teams work at full scope in Australia, in order to improve access to care for patients.
“We know people get the best outcomes when their GP works together with their other specialists, and health professionals, and it’s especially valuable for people with chronic and complex illnesses.
Source: Highlights from RACGP media release
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
-
Reflecting on a pivotal year for pharmacy
Dr. Kate Wang, a Senior Lecturer in Pharmacy at RMIT University and Adjunct Senior Lecturer, University of Western Australia, has over a decade of experience in both hospital and community pharmacy settings.
Dr Wang spoke to Australian Health Journal on some of the key topics in 2024 that have been pivotal as a pharmacist, academic and researcher for the pharmacy profession.
-
Maximising benefits, minimising harms in population health screening
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
